Stockreport

BiomX Provides Update on BX004 Phase 2b Trial in Cystic Fibrosis

BiomX Inc. COmmon Stock  (PHGE) 
PDF The Company continues working with the third-party manufacturer to address recent FDA follow-up information requests which are required to lift the clinical hold concern [Read more]